Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medifast's enterprise value is MXN70 Mil.
Medifast's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-102 Mil. Therefore, Medifast's EV-to-EBITDA for today is -0.69.
The historical rank and industry rank for Medifast's EV-to-EBITDA or its related term are showing as below:
MEX:MED'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -1694.21 Med: 11.07 Max: 52.01
Current: -2.25
During the past 13 years, the highest EV-to-EBITDA of Medifast was 52.01. The lowest was -1694.21. And the median was 11.07.
MEX:MED's EV-to-EBITDA is ranked better than 90.67% of 75
companies
in the Personal Services industry
Industry Median: 7.38
vs MEX:MED: -2.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2026-08-05), Medifast's stock price is MXN180.00.
Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-41.940. Therefore, Medifast's PE Ratio (TTM) for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medifast's share price for today is MXN180.00.
Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-41.940.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Medifast's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MED vs RGS, CLIK, EVTK: EV-to-EBITDA Comparison
For the Personal Services subindustry, Medifast's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast EV-to-EBITDA vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Medifast's EV-to-EBITDA falls into.
Medifast's current Enterprise Value is MXN70 Mil.
Medifast's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-102 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (MEX:MED) has a EV-to-EBITDA of -0.69 as of Aug. 05, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medifast. According to the industry distribution chart, Medifast ranks #7 out of 75 companies in the Personal Services industry, placing it in the top 9.3%.
Is Medifast's EV-to-EBITDA too high?
Medifast's current EV-to-EBITDA is -0.69. Based on the distribution chart, Medifast ranks #7 out of 75 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Medifast's EV-to-EBITDA compare to RGS and CLIK?
According to the Personal Services industry distribution chart, Medifast ranks #7 out of 75 companies for EV-to-EBITDA. This places Medifast in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 7.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Personal Services company?
The median EV-to-EBITDA among Personal Services companies is 7.38, based on 75 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Medifast. For the Personal Services industry, the median EV-to-EBITDA is 7.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current EV-to-EBITDA is -0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Medifast (MEX:MED) has a current EV-to-EBITDA of -0.69. The stock's GF Value™ is MXN156.53, compared to a current price of MXN180.00 — trading 15% above its estimated fair value. The current EV-to-EBITDA is -0.69. Medifast's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Medifast (MEX:MED), the current EV-to-EBITDA is -0.69 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (MEX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of MXN180.00 is trading 15% above its estimated GF Value™ of MXN156.53.
Key valuation signals for MEX:MED:
EV-to-EBITDA: -0.69
GF Value™: MXN156.53 vs. price of MXN180.00 (15% above fair value)
No single metric tells the full story. See the MEX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
63GF Score
Get the complete analysis for MEX:MED
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MED has been successfully added to your 
